CSF3 and Decreased total granulocyte count: The Food and Drug Administration approves G-CSF, and its indications are autologous bone marrow transplantation, chemotherapy-induced granulocytopenia, AIDS, etc (Wallner et al., 2015) According to their mechanism of action, G-CSF is divided into granulocyte-derived and granulocyte-macrophage-derived forms.